215 related articles for article (PubMed ID: 30537730)
1. miR-494 Sensitizes Gastric Cancer Cells to TRAIL Treatment Through Downregulation of Survivin.
Xu S; Li D; Li T; Qiao L; Li K; Guo L; Liu Y
Cell Physiol Biochem; 2018; 51(5):2212-2223. PubMed ID: 30537730
[TBL] [Abstract][Full Text] [Related]
2. miR-128 Targets the SIRT1/ROS/DR5 Pathway to Sensitize Colorectal Cancer to TRAIL-Induced Apoptosis.
Lian B; Yang D; Liu Y; Shi G; Li J; Yan X; Jin K; Liu X; Zhao J; Shang W; Zhang R
Cell Physiol Biochem; 2018; 49(6):2151-2162. PubMed ID: 30257253
[TBL] [Abstract][Full Text] [Related]
3. Combination of AAV-TRAIL with miR-221-Zip Therapeutic Strategy Overcomes the Resistance to TRAIL Induced Apoptosis in Liver Cancer.
Ma S; Sun J; Guo Y; Zhang P; Liu Y; Zheng D; Shi J
Theranostics; 2017; 7(13):3228-3242. PubMed ID: 28900506
[TBL] [Abstract][Full Text] [Related]
4. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells.
Li J; Sun RR; Yu ZJ; Liang H; Shen S; Kan Q
Cancer Biother Radiopharm; 2015 Oct; 30(8):336-41. PubMed ID: 26348206
[TBL] [Abstract][Full Text] [Related]
5. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway.
Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y
Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099
[TBL] [Abstract][Full Text] [Related]
6. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
7. Cyclopamine sensitizes TRAIL-resistant gastric cancer cells to TRAIL-induced apoptosis via endoplasmic reticulum stress-mediated increase of death receptor 5 and survivin degradation.
Na YJ; Lee DH; Kim JL; Kim BR; Park SH; Jo MJ; Jeong S; Kim HJ; Lee SY; Jeong YA; Oh SC
Int J Biochem Cell Biol; 2017 Aug; 89():147-156. PubMed ID: 28624529
[TBL] [Abstract][Full Text] [Related]
8. miR-34a Enhances the Susceptibility of Gastric Cancer to Platycodin D by Targeting Survivin.
Peng Y; Fan JY; Xiong J; Lou Y; Zhu Y
Pathobiology; 2019; 86(5-6):296-305. PubMed ID: 31711057
[TBL] [Abstract][Full Text] [Related]
9. miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway.
Cao W; Yang W; Fan R; Li H; Jiang J; Geng M; Jin Y; Wu Y
Tumour Biol; 2014 Feb; 35(2):1287-95. PubMed ID: 24068565
[TBL] [Abstract][Full Text] [Related]
10. The mechanism study of lentiviral vector carrying methioninase enhances the sensitivity of drug-resistant gastric cancer cells to Cisplatin.
Xin L; Yang WF; Zhang HT; Li YF; Liu C
Br J Cancer; 2018 May; 118(9):1189-1199. PubMed ID: 29576621
[TBL] [Abstract][Full Text] [Related]
11. MiR-126 reverses drug resistance to TRAIL through inhibiting the expression of c-FLIP in cervical cancer.
Zhang W; Zhou J; Zhu X; Yuan H
Gene; 2017 Sep; 627():420-427. PubMed ID: 28669929
[TBL] [Abstract][Full Text] [Related]
12. miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT.
Liu N; Zuo C; Wang X; Chen T; Yang D; Wang J; Zhu H
Oncotarget; 2014 Jul; 5(13):4959-71. PubMed ID: 24970806
[TBL] [Abstract][Full Text] [Related]
13. Thiourea compound AW00178 sensitizes human H1299 lung carcinoma cells to TRAIL-mediated apoptosis.
Ryu BJ; Hwang MK; Park M; Lee K; Kim SH
Bioorg Med Chem Lett; 2012 Jun; 22(12):3862-5. PubMed ID: 22622069
[TBL] [Abstract][Full Text] [Related]
14. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
[TBL] [Abstract][Full Text] [Related]
15. MiR-106b inhibitors sensitize TRAIL-induced apoptosis in hepatocellular carcinoma through increase of death receptor 4.
Xu C; Shi L; Chen W; Fang P; Li J; Jin L; Pan Z; Pan C
Oncotarget; 2017 Jun; 8(26):41921-41931. PubMed ID: 28410209
[TBL] [Abstract][Full Text] [Related]
16. Aplysin sensitizes cancer cells to TRAIL by suppressing P38 MAPK/survivin pathway.
Liu J; Ma L; Wu N; Liu G; Zheng L; Lin X
Mar Drugs; 2014 Sep; 12(9):5072-88. PubMed ID: 25257790
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of microRNA-193-3p inhibits tumor proliferation migration and chemoresistance in human gastric cancer by regulating PTEN gene.
Jian B; Li Z; Xiao D; He G; Bai L; Yang Q
Tumour Biol; 2016 Jul; 37(7):8941-9. PubMed ID: 26753960
[TBL] [Abstract][Full Text] [Related]
18. Irigenin sensitizes TRAIL-induced apoptosis via enhancing pro-apoptotic molecules in gastric cancer cells.
Xu Y; Gao CC; Pan ZG; Zhou CW
Biochem Biophys Res Commun; 2018 Feb; 496(3):998-1005. PubMed ID: 29305260
[TBL] [Abstract][Full Text] [Related]
19. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
[TBL] [Abstract][Full Text] [Related]
20. Understanding of tolerance in TRAIL-induced apoptosis and cancelation of its machinery by α-mangostin, a xanthone derivative.
Kumazaki M; Shinohara H; Taniguchi K; Ueda H; Nishi M; Ryo A; Akao Y
Oncotarget; 2015 Sep; 6(28):25828-42. PubMed ID: 26304927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
